b'Driven to Bring Technologies to Market DATA COURTESY OF COLORADOS CLINICAL ASSETSDRUGSDRUGS BY PHASEDISCOVERY 29.8% PRECLINICAL 46.8% PHASE 1 9.2%PHASE 2 5.8%PHASE 3 0.7%MARKETED 7.8%DRUGS BY SPECIALTY All Phases of Development28.0 % 16.2 %9.8 %8.1%ONCOLOGY CENTRAL NERVOUSINFECTIOUS IMMUNOLOGYSYSTEM DISEASE7.15.1 % 21.6 %% % 4.1METABOLICRESPIRATORY CARDIOVASCULAR ALL OTHERDISORDERS2025-2026 BIOSCIENCE COLORADO 23'